secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aclarion, Inc. (ACON)
CIK:        0001635077
Form:       8-K
Filed at:   2023-03-07T23:59:59+00:00
Accession:  0001683168-23-001360
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Aclarion receives Nasdaq equity deficiency notice; stockholders' equity $1.79M vs $2.5M minimum
--------------------------------------------------------------------------------

- Stockholders' equity reported at $1,787,751 as of Dec 31, 2023 falls below $2.5M Nasdaq minimum.
- Company must submit compliance plan by April 17, 2023; extension possible to Aug 30, 2023.
- Separately, Nasdaq bid price deficiency notice received Dec 20, 2022; cure period through June 20, 2023.
- No immediate impact on listing; company evaluating options including a potential reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1635077/000168316823001360/0001683168-23-001360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1635077/000168316823001360/aclarion_8k-030323.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-001360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer